During the most recent 90-day period, prior to the date of this filing, there have been 11 insider transactions reported to the SEC for Veracyte. These transactions came from the activities of 4 individual insiders that resulted in a net acquisition of 23,576 company shares. This compares with the preceding 90-day window of time where there were 26 transactions from 6 insiders that resulted in the net disposition of 1,026,707 shares.
This level of insider transactions is below that of the peer group average in the 10-company Bio Diagnostics & Testing peer group over the last 90-day period. Peer group activity averaged 34.9 transactions per company, with company insiders acquiring on average 236,190 shares.
SEC Story Link http://www.sec.gov/Archives/edgar/data/1384101/000138410119000102/xslF345X03/wf-form4_156503623993677.xml
|Insider Trends: 90-Day Insider Buying Trend at Guide...|
|Insider Trends: 90-Day Insider Buying Trend Reduced ...|
|Insider Trends: 90-Days of Insider Buying at Guidewi...|
|Insider Trends: Guidewire Software Sees 90 Days of I...|
|Insider Trends: Insider Adds to Selling Trend at Eag...|